Properties
Description
NRC-AN-019 specifically inhibits the activity of the Bcr-Abl tyrosine kinase.
Molecular Formula
C25H17F6N5O
Identity
Confirmed by NMR/HPLC/MS.
Applications
NRC-AN-019 acts as a Bcr-Abl inhibitor, contributing to leukemia research.